Results 151 to 160 of about 86,878 (224)
Some of the next articles are maybe not open access.

Nanostim—leadless pacemaker

Herzschrittmachertherapie + Elektrophysiologie, 2018
Nanostim™ (St. Jude Medical Inc., Saint Paul, MN, USA; now Abbott Medical Inc. Abbott Park, IL, USA) was the first self-contained intracardiac pacemaker to be implanted in a human patient. A total of 1423 Nanostim devices were implanted worldwide between 2013 and 2016 and three clinical trials were initiated.
Johannes, Sperzel   +2 more
openaire   +2 more sources

Cremation of Leadless Pacemaker

Pacing and Clinical Electrophysiology, 2017
Cremation of implanted cardiac electronic devices can be associated with explosion from rapid gas formation causing potential hazard to the crematoria staffs and facilities. We present four patients who had undergone cremation with a leadless pacemaker (MicraTM, Medtronic Inc., Minneapolis, MN, USA) left inside their bodies.
LILY CHEUNG   +3 more
openaire   +2 more sources

“Challenges” During Leadless Pacemaker Implantation

Cardiology in Review, 2023
Leadless pacemaker (LP) is a new type of pacemaker that integrates generator and leads, and has become an effective alternative to traditional transvenous pacemakers. It can be used for difficult or complicated situations of traditional pacemaker implantation, such as subclavian vein occlusion, traditional pacemaker pocket infection, lead fracture, and
Shuyun, Le   +3 more
openaire   +2 more sources

Systematic review of leadless pacemaker

Acta Cardiologica, 2023
Conventional pacing systems consist of a pacemaker and one or more leads threaded from the device pocket through veins into the heart conducting the pacing therapy to the desired pacing site. Although these devices are effective, approximately one in eight patients treated with these traditional pacing systems experiences a complication attributed to ...
Fukang, Xu   +5 more
openaire   +2 more sources

First-in-Human Study of a Leadless Pacemaker System for Left Bundle Branch Area Pacing.

Heart Rhythm
BACKGROUND Leadless pacemakers (LP) are limited by the current inability to perform left bundle branch area pacing (LBBAP). OBJECTIVE This first-in-human acute feasibility study evaluated the safety and performance of a novel helix-based LP with an ...
Vivek Y. Reddy   +8 more
semanticscholar   +1 more source

Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study

Europace
Aims A dual-chamber leadless pacemaker (LP) system that employs distinct atrial and ventricular LP devices (ALP, VLP) has been introduced to clinical practice.
Vivek Y. Reddy   +13 more
semanticscholar   +1 more source

Case report demonstrating novel approaches for leadless pacemaker implantation in the single ventricle heart

European Heart Journal: Case Reports
Background The congenital heart disease population can provide a unique set of challenges during pacemaker implant, including the necessity of transvenous leads in a young group of patients.
P. Hayle   +4 more
semanticscholar   +1 more source

One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker

Circulation: Arrhythmia and Electrophysiology
BACKGROUND: A dual-chamber leadless pacemaker can provide bradycardia therapy to most patients with pacemaker indications without the complications associated with a lead or pulse generator. We sought to confirm whether previously reported 3-month safety
R. Knops   +16 more
semanticscholar   +1 more source

Commercial Implant Experience of a Helix‐Fixation Dual‐Chamber Leadless Pacemaker

Cardiovascular Electrophysiology
The AVEIR DR pacemaker (Abbott) is a dual‐chamber leadless pacemaker (LP) system that includes right atrial and right ventricular helix‐fixation LPs (ALP, VLP), with atrioventricular synchrony maintained via wireless communication between the two devices.
C. Hadadi   +11 more
semanticscholar   +1 more source

Leadless Pacemaker vs. Transvenous Pacemaker in End Stage Kidney Disease: Insights from the Nationwide Readmission Database

Journal of Clinical Medicine
Background: Leadless pacemakers offer a safe and effective alternative pacing strategy. However, limited data are available for patients with end stage renal disease (ESRD), a population of significant relevance. Methods: Using the Nationwide Readmission
Sajog Kansakar   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy